Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07605507
What this trial is testing

Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer

Who this might be right for
Cervical Cancer
Siriraj Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00214097
What this trial is testing

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 347
Not applicableStudy completedNCT03880396
What this trial is testing

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Assiut University 62
Testing effectiveness (Phase 2)Study completedNCT03345420
What this trial is testing

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage 0 Breast Cancer+6 more
University of Utah 102
Not applicableUnknownNCT04812145
What this trial is testing

Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma

Who this might be right for
Urinary Bladder Cancer
Assiut University 50
Not applicableLooking for participantsNCT07299812
What this trial is testing

BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART

Who this might be right for
Breast CancerRadiotherapy
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Testing effectiveness (Phase 2)Looking for participantsNCT06677879
What this trial is testing

A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.

Who this might be right for
Breast Cancer
Shanghai Proton and Heavy Ion Center 780
Large-scale testing (Phase 3)Study completedNCT00793962
What this trial is testing

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 810
Testing effectiveness (Phase 2)Looking for participantsNCT05692674
What this trial is testing

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Who this might be right for
Breast Cancer
Shanghai Proton and Heavy Ion Center 67
Early research (Phase 1)Active Not RecruitingNCT04046575
What this trial is testing

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Who this might be right for
Esophagus CancerEsophageal CancerCancer of the Esophagus
Washington University School of Medicine 12
Testing effectiveness (Phase 2)UnknownNCT01000129
What this trial is testing

Adaptive Planning in Bladder Cancer

Who this might be right for
Bladder Cancer
Royal Marsden NHS Foundation Trust 32
Testing effectiveness (Phase 2)UnknownNCT05603013
What this trial is testing

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma Breast
Second Affiliated Hospital of Soochow University 45
Large-scale testing (Phase 3)Study completedNCT07590505
What this trial is testing

Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research Antwerp 132
Not applicableUnknownNCT03194061
What this trial is testing

Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

Who this might be right for
Radiotherapy; Complications
Barretos Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03778294
What this trial is testing

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Who this might be right for
GlioblastomaMalignant Glioma
Mayo Clinic 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497
What this trial is testing

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Who this might be right for
Non Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more
Megan Daly, MD 18
Large-scale testing (Phase 3)Looking for participantsNCT05856773
What this trial is testing

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

Who this might be right for
Breast Cancer
Proton Collaborative Group 276
Not applicableStudy completedNCT04842409
What this trial is testing

Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery

Who this might be right for
Breast CancerRadiotherapy Side Effect
Azienda Ospedaliero-Universitaria Careggi 50
Not applicableUnknownNCT03750539
What this trial is testing

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

Who this might be right for
Cervix Cancer
National Institute of Cancerología 100
Testing effectiveness (Phase 2)Looking for participantsNCT07691619
What this trial is testing

Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial Tumor
Tianjin Medical University Cancer Institute and Hospital 49
Next Page